Orphan drugs are designated for use in the treatment of rare and new diseases such as Fragile X Syndrome and Huntington's disease. These conditions have limited to no adequate treatment options and therefore rely on orphan drugs. Certain drugs are given orphan status under the primary requirement that a condition affect
